Western European IVD Industry Growth Opportunities to 2021 - Increased R&D Investments and M&As Propel the Growth of Mobile POCT and Clinical Genomics Solutions

News provided by

Research and Markets

13 Jul, 2017, 14:30 GMT

DUBLIN, July 13, 2017 /PRNewswire/ --

The "Growth Opportunities in the Western European IVD Industry, Forecast to 2021" report has been added to Research and Markets' offering.

This study offers comprehensive information on every aspect of the IVD market. It is segmented into 8 subdivisions, namely, immunochemistry, POCT, SMBG, molecular diagnostics, clinical microbiology, haemostasis, hematology, and tissue diagnostics. Discussion on key trends and opportunities and company profile analysis by segment are also provided. In addition, there are dedicated country chapters for the key Western European markets (Germany, France, the United Kingdom, Spain, Italy, Benelux, and Scandinavia) and a snapshot of the regulatory policies awaiting to transform the industry.

Despite global economic and industry challenges, in-vitro diagnostics (IVD) markets continue to grow, mainly due to fast-growing segments like molecular diagnostics, point-of-care testing (POCT), and tissue diagnostics.. A few market dynamics are either positively or negatively affecting certain specific segments in the IVD space; for example, the self-monitoring blood glucose (SMBG) segment's growth in emerging markets is severely dampened by the slowing growth from reimbursement reductions in Western Europe.The broad applicability of POCT, combined with downward pricing trends enabled by microfluidics integration, supports the long-term growth of this segment. The Western European markets continue to drive molecular diagnostics segment growth rather than the emerging Eastern European markets.

The recent success of companion diagnostic tests and personalised medicine is driving the uptake of various tests in an aim to save costs, thus opening up an opportunity to expand the test menus in existing installs. Diagnostic testing will continue to move towards process simplicity and decentralisation. IVD market participants are expected to employ a diverse set of strategies rather than rely on comprehensive product portfolios to grow their businesses. Companies are also gaining new market access through acquisitions, and this has intensified competition among tier 1 participants.

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Market Dynamics-Western Europe

4. Trend Analysis-Western European IVD Market

5. Emerging Technologies in the Western European IVD Market

6. Regional Analysis-Western Europe

7. Drivers and Restraints-IVD Market

8. Growth Opportunities and Companies to Action

9. Revenue Forecast-IVD Market

10. Segment Analysis-IVD Market

11. Immunochemistry Segment Analysis

12. Molecular Diagnostics Segment Analysis

13. POCT Segment Analysis

14. Tissue Diagnostics Segment Analysis

15. Self-monitoring Blood Glucose Segment Analysis

16. Clinical Microbiology Segment Analysis

17. Haemostasis Segment Analysis

18. Haematology Segment Analysis

19. Conclusion

Companies Mentioned

  • Abbott
  • Affymetrix
  • Alere
  • Becton Dickinson
  • Biomerieux
  • Cephed
  • Danaher
  • Gen-Probe
  • Grifols
  • Hologic
  • Horiba
  • Illumina
  • Meridian
  • Orthoclinical Diagnostics
  • Perkin-Elmer
  • Qiagen
  • Roche
  • Siemens
  • Sysmex
  • Thermofisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/z8dw9b/growth

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com